PT - JOURNAL ARTICLE AU - Lina Guan AU - Christophe Prieur AU - Liguo Zhang AU - Clémentine Prieur AU - Didier Georges AU - Pascal Bellemain TI - Transport effect of COVID-19 pandemic in France AID - 10.1101/2020.07.27.20161430 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.27.20161430 4099 - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20161430.short 4100 - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20161430.full AB - An extension of the classical pandemic SIRD model is considered for the regional spread of COVID-19 in France under lockdown strategies. This compartment model divides the infected and the recovered individuals into undetected and detected compartments respectively. By fitting the extended model to the real detected data during the lockdown, an optimization algorithm is used to derive the optimal parameters, the initial condition and the epidemics start date of regions in France. Considering all the age classes together, a network model of the pandemic transport between regions in France is presented on the basis of the regional extended model and is simulated to reveal the transport effect of COVID-19 pandemic after lockdown. Using the the measured values of displacement of people mobilizing between each city, the pandemic network of all cities in France is simulated by using the same model and method as the pandemic network of regions. Finally, a discussion on an integro-differential equation is given and a new model for the network pandemic model of each age class is provided.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo.Funding StatementNo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCalibrate on daily data for H, U, D and R+ on the lockdown period 2020-03-18 to 2020-05-11 from two data sources: the first one is Gouvernement fran ̧cais, Info coronavirus covid 19, and the second one is Minist`ere des solidarit ́es et de la sant ́e, Plateforme COVID-19. https://www.gouvernement.fr/info-coronavirus/carte-et-donnees https://www.francetvinfo.fr/sante/maladie/coronavirus/coronavirus-450-personnes-en-quatorzaine-apres-des-cas-dans-une-ecole-de-lyon_4036889.html